Guangzhou Kingmed Diagnostics Group Co., Ltd. Share Price
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.18 CNY | -1.02% |
|
+2.37% | +9.63% |
| Capitalization | 1.4TCr 196.71Cr 169.6Cr 156.48Cr 149.33Cr 275.95Cr 17TCr 302.48Cr 1.86TCr 717.42Cr 8.32TCr 737.72Cr 722.59Cr 31TCr | P/E ratio 2025 * |
425x | P/E ratio 2026 * | 27x |
|---|---|---|---|---|---|
| Enterprise value | 1.13TCr 158.9Cr 137Cr 126.41Cr 120.63Cr 222.91Cr 14TCr 244.34Cr 1.5TCr 579.53Cr 6.72TCr 595.93Cr 583.71Cr 25TCr | EV / Sales 2025 * |
1.84x | EV / Sales 2026 * | 1.62x |
| Free-Float |
53.05% | Yield 2025 * |
0.2% | Yield 2026 * | 1.33% |
| 1 day | -1.02% | ||
| 1 week | +2.37% | ||
| Current month | +0.94% | ||
| 1 month | +5.93% | ||
| 3 months | +0.07% | ||
| 6 months | -1.05% | ||
| Current year | +9.63% |
| 1 week | 29.65 | 31.15 | |
| 1 month | 27.99 | 31.15 | |
| Current year | 24.35 | 42 | |
| 1 year | 24.35 | 42 | |
| 3 years | 24.35 | 92.91 | |
| 5 years | 24.35 | 178.88 | |
| 10 years | 9.98 | 178.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yao Ming Liang
CEO | Chief Executive Officer | 61 | 01/01/2006 |
Bi Xi Hao
DFI | Director of Finance/CFO | 55 | 26/06/2015 |
Xiao Feng Zou
PRN | Corporate Officer/Principal | 45 | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Yao Ming Liang
CHM | Chairman | 61 | 01/01/2006 |
Ting Yan
BRD | Director/Board Member | 56 | 01/01/2006 |
Zhan Wen Zeng
BRD | Director/Board Member | 59 | 01/01/2006 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.02% | +2.37% | -8.74% | -59.68% | 198.97Cr | ||
| +0.86% | +3.24% | +41.07% | +460.96% | 2.82TCr | ||
| -0.64% | -1.21% | -20.36% | -36.13% | 690.15Cr | ||
| +2.51% | -1.62% | -3.19% | +366.06% | 579.75Cr | ||
| +1.16% | -7.29% | +89.32% | +426.95% | 370.15Cr | ||
| -0.07% | +2.16% | +6.35% | +31.16% | 297.13Cr | ||
| +8.45% | +0.51% | +14.60% | -3.28% | 164.12Cr | ||
| -1.76% | +0.31% | +23.74% | -43.16% | 141.61Cr | ||
| -1.16% | +1.39% | -32.05% | -8.09% | 133.79Cr | ||
| -0.74% | -7.29% | +47.04% | +30.17% | 130.99Cr | ||
| Average | +0.80% | -2.21% | +15.78% | +116.50% | 552.6Cr | |
| Weighted average by Cap. | +1.07% | -1.42% | +25.46% | +296.51% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 612.98Cr 86Cr 74Cr 69Cr 65Cr 120.98Cr 7.64TCr 132.62Cr 815.84Cr 314.54Cr 3.65TCr 323.44Cr 316.81Cr 13TCr | 709.27Cr 100Cr 86Cr 79Cr 76Cr 139.99Cr 8.84TCr 153.45Cr 944Cr 363.95Cr 4.22TCr 374.25Cr 366.58Cr 15TCr |
| Net income | 3.26Cr 45.88L 39.56L 36.5L 34.83L 64.36L 41Cr 70.55L 4.34Cr 1.67Cr 19Cr 1.72Cr 1.69Cr 71Cr | 52Cr 7.3Cr 6.29Cr 5.81Cr 5.54Cr 10Cr 646.55Cr 11Cr 69Cr 27Cr 308.79Cr 27Cr 27Cr 1.13TCr |
| Net Debt | -268.72Cr -38Cr -33Cr -30Cr -29Cr -53Cr -3.35TCr -58Cr -357.66Cr -137.89Cr -1.6TCr -141.79Cr -138.89Cr -5.87TCr | -247.58Cr -35Cr -30Cr -28Cr -26Cr -49Cr -3.09TCr -54Cr -329.52Cr -127.04Cr -1.47TCr -130.64Cr -127.96Cr -5.4TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/25/17 | 30.18 ¥ | -1.02% | 39,16,006 |
| 14/25/14 | 30.49 ¥ | +1.26% | 68,86,308 |
| 13/25/13 | 30.11 ¥ | -0.13% | 33,59,914 |
| 12/25/12 | 30.15 ¥ | +0.80% | 45,97,114 |
| 11/25/11 | 29.91 ¥ | -0.37% | 25,01,214 |
End-of-day quote Shanghai S.E., November 17, 2025
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 603882 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















